Skip to main content
EJNMMI Research
Fig. 3 | EJNMMI Research

Fig. 3

From: Validation of [18F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor

Fig. 3

An overview of the multiparametric evaluation of TBF and [18F]FLT uptake. a [18F]FLT PET scan. b Parametric VOI image of [15O]H2O derived TBF. c Parametric VOI image of [18F]FLT V T . d Voxels classified as low or high TBF. e Voxels classified as low or high [18F]FLT V T . f Voxels classified into four categories: lowTBF-lowV T , lowTBF-highV T , highTBF-lowV T and highTBF-highV T

Back to article page